Literature DB >> 29175369

Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria.

Matthew D Straesser1, Eric Oliver2, Thamiris Palacios1, Timothy Kyin1, James Patrie3, Larry Borish4, Sarbjit S Saini2, Monica G Lawrence5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29175369      PMCID： PMC5966318          DOI： 10.1016/j.jaip.2017.10.030

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  8 in total

1.  Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria.

Authors:  Allen Kaplan; Marta Ferrer; Jonathan A Bernstein; Evgeniya Antonova; Benjamin Trzaskoma; Karina Raimundo; Karin Rosén; Theodore A Omachi; Sam Khalil; James L Zazzali
Journal:  J Allergy Clin Immunol       Date:  2015-10-21       Impact factor: 10.793

2.  Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria.

Authors:  Ravi K Viswanathan; Mark H Moss; Sameer K Mathur
Journal:  Allergy Asthma Proc       Date:  2013 Sep-Oct       Impact factor: 2.587

3.  Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.

Authors:  Marcus Maurer; Karin Rosén; Hsin-Ju Hsieh; Sarbjit Saini; Clive Grattan; Ana Gimenéz-Arnau; Sunil Agarwal; Ramona Doyle; Janice Canvin; Allen Kaplan; Thomas Casale
Journal:  N Engl J Med       Date:  2013-02-24       Impact factor: 91.245

4.  Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticaria.

Authors:  Thamiris Palacios; Leland Stillman; Larry Borish; Monica Lawrence
Journal:  J Allergy Clin Immunol Pract       Date:  2015-12-24

Review 5.  Omalizumab for the Treatment of Chronic Idiopathic Urticaria: Systematic Review of the Literature.

Authors:  Alessandro Tonacci; Lucia Billeci; Giovanni Pioggia; Michele Navarra; Sebastiano Gangemi
Journal:  Pharmacotherapy       Date:  2017-03-23       Impact factor: 4.705

6.  Omalizumab-induced reductions in mast cell Fce psilon RI expression and function.

Authors:  Lisa A Beck; Gregory V Marcotte; Donald MacGlashan; Alkis Togias; Sarbjit Saini
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

7.  Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.

Authors:  Martin Metz; Tatevik Ohanyan; Martin K Church; Marcus Maurer
Journal:  J Dermatol Sci       Date:  2013-09-03       Impact factor: 4.563

8.  IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria?

Authors:  Sabine Altrichter; Hans-Jürgen Peter; Dina Pisarevskaja; Martin Metz; Peter Martus; Marcus Maurer
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240
  8 in total
  14 in total

1.  New insights into the utility of omalizumab.

Authors:  Juan Carlos Cardet; Thomas B Casale
Journal:  J Allergy Clin Immunol       Date:  2019-01-26       Impact factor: 10.793

2.  Combination therapy with omalizumab and an immune-suppressive agent for resistant chronic spontaneous rrticaria - A real-life experience.

Authors:  Ramit Maoz-Segal; Tanya Levy; Soad Haj-Yahia; Irena Offengenden; Mona Iancovich-Kidon; Nancy Agmon-Levin
Journal:  World Allergy Organ J       Date:  2020-08-04       Impact factor: 4.084

Review 3.  Chronic Spontaneous Urticaria: The Devil's Itch.

Authors:  Sarbjit S Saini; Allen P Kaplan
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jul - Aug

Review 4.  Update on Omalizumab for Urticaria: What's New in the Literature from Mechanisms to Clinic.

Authors:  Désirée E S Larenas-Linnemann; Claudio A S Parisi; Carla Ritchie; Ricardo Cardona-Villa; Ivan Cherrez-Ojeda; Annia Cherrez; Luis Felipe Ensina; Elizabeth Garcia; Iris V Medina; Mónica Rodríguez-González; Jorge Mario Sánchez Caraballo
Journal:  Curr Allergy Asthma Rep       Date:  2018-05-09       Impact factor: 4.806

5.  The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.

Authors:  Kirti J Johal; Kristin L Chichester; Eric T Oliver; Kelly C Devine; Anja P Bieneman; John T Schroeder; Donald W MacGlashan; Sarbjit S Saini
Journal:  J Allergy Clin Immunol       Date:  2021-03-10       Impact factor: 14.290

Review 6.  Emerging Therapies in Chronic Spontaneous Urticaria.

Authors:  Taek Ki Min; Sarbjit S Saini
Journal:  Allergy Asthma Immunol Res       Date:  2019-07       Impact factor: 5.764

7.  Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications.

Authors:  Ilaria Puxeddu; Fiorella Petrelli; Francesca Angelotti; Cristina Croia; Paola Migliorini
Journal:  J Asthma Allergy       Date:  2019-09-20

8.  Anxiety, depression, and stress in Korean patients with chronic urticaria.

Authors:  Gil-Soon Choi; Young-Hee Nam; Chan-Sun Park; Mi-Yeong Kim; Eun-Jung Jo; Hye-Kyung Park; Hee-Kyoo Kim
Journal:  Korean J Intern Med       Date:  2020-05-27       Impact factor: 2.884

Review 9.  Total IgE as a Marker for Chronic Spontaneous Urticaria.

Authors:  Sabine Altrichter; Jie Shen Fok; Qingqing Jiao; Pavel Kolkhir; Polina Pyatilova; Sherezade Moñino Romero; Jörg Scheffel; Frank Siebenhaar; Carolin Steinert; Dorothea Terhorst-Molawi; Yi Kui Xiang; Martin K Church; Marcus Maurer
Journal:  Allergy Asthma Immunol Res       Date:  2021-03       Impact factor: 5.764

10.  The Relation of Autologous Serum Skin Test and Autologous Plasma Skin Test Result with Various Clinical and Laboratory Findings in Patients with Chronic Spontaneous Urticaria.

Authors:  Gyeong-Hun Park; Jeong-Hee Choi; Sunmi Kim; Youin Bae
Journal:  Ann Dermatol       Date:  2020-06-30       Impact factor: 1.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.